{"id":3971,"date":"2011-09-06T21:21:11","date_gmt":"2011-09-06T21:21:11","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=4180"},"modified":"2011-09-06T21:21:11","modified_gmt":"2011-09-06T21:21:11","slug":"medical-marijuana-inc-otc-mjna-marijuana-extract-cannabidiol-cbd-possible-use-as-a-prevention-and-treatment-to-alzheimers-disease","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2011\/09\/06\/medical-marijuana-inc-otc-mjna-marijuana-extract-cannabidiol-cbd-possible-use-as-a-prevention-and-treatment-to-alzheimers-disease\/","title":{"rendered":"Medical Marijuana Inc. (OTC: MJNA) Marijuana Extract Cannabidiol (CBD) Possible Use As A Prevention And Treatment To Alzheimer\u2019s Disease"},"content":{"rendered":"
A Disease That affects 5.6 Million People And Costs $182 Billion Annually In The United States.Medical Marijuana Inc. Patent Pending Extraction Method Is Used To Isolate Cannabidiol From Marijuana Without Any Other Psychoactive Properties.<\/p>\n
SAN DIEGO, CA–(Business Wire \u2013 Sept 6, 2011) – Medical Marijuana Inc (OTC: MJNA) is pleased to announce that studies have shown Cannabidiol (CBD) as a possible prevention and treatment for Alzheimer\u2019s disease. Medical Marijuana Inc. through CannaBANK has a patent pending on an extraction method from Cannabis Sativa (Marijuana) and its industrialized non psychoactive counterpart Hemp, allowing Cannabidiol (CBD) to be isolated in its pure form.<\/p>\n
According to the Alzheimer\u2019s Association (www.alz.org<\/a>) Alzheimer\u2019s is said to cost $182 billion annually and is the 6th leading cause of death in the United States. This affects some 14.9 million family members and friends of Alzheimer\u2019s patients, these family and friends provide an estimated 17 billion hours annually of unpaid care. With the recent explosion of Cannabis (Marijuana) research over the past decade, research has shown that Cannabidiol (CBD) has a neuroprotective, anti-inflammatory, anti-oxidative and anti-apoptotic effect, which is associated with oxidative stress commonly known to be a cause of Alzheimer\u2019s disease.<\/p>\n Medical Marijuana Inc. is planning on expanding its Cannabidiol sales through licensing agreements with companies already involved in the heavily marketed nutraceutical and pharmaceutical markets.<\/p>\n Resources and Abstracts:<\/p>\n United States National Library of Medicine (PubMed)<\/p>\n http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15030397<\/a><\/p>\n http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18833429<\/a><\/p>\n http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21350020<\/a><\/p>\n http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15728830<\/a><\/p>\n http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16266285<\/a><\/p>\n http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19228180<\/a><\/p>\n http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17592514<\/a><\/p>\n http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16490313<\/a><\/p>\n ABOUT MEDICAL MARIJUANA INC (OTC: MJNA)<\/p>\n Our mission is to be the world’s premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate, invest in and purchase value-added sustainable companies, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, pay homage to the visionaries and activists of the past and present, and provide the platform from which the industry can emerge into a global sustainable economy for all. Medical Marijuana Inc recognizes the vast and unequaled opportunities that exist in the rapidly expanding hemp and medical marijuana industries. The scientific recognition of cannabis has brought legalized marijuana use to the forefront of mainstream discussion, thus opening the door for safe and lucrative investment opportunities.<\/p>\n